Lipitor Again

Just before I get onto the motorway I should mention an article by Alex Benerson in today’s New York Times entitled “Lipitor or Generic? Billion-Dollar Battle Looms” which provides more background information for the Ranbaxy case. The key point of the article is that “spending on prescription drugs has jumped from US$40 billion in 1990 to almost US$250 billion this year, and continues to rise faster than overall inflation.” Interestingly, the article also reports resistance by doctors and patients to migrating from to a generic even after a patent expires.

It is necessary to register to access NYT articles. Registration is free. It’s as well to move quickly, however, because the NYT charges for archived material.

Advertisements

About Jane Lambert

I am a barrister specializing in intellectual property, technology, media and entertainment and competition law. I specialize in helping SME (small and medium enterprises) protect and exploit their investment in brands, design, technology and the arts. SME require intellectual property (legal protection for their intellectual assets) at least as much as big business but their limited means restrict the way they can use it. Looking after such clients wisely requires skills and knowledge which have taken me years to learn.
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s